TGen/APNNA is a clinical research site located in Phoenix, Arizona, United States 85012.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
TGen/APNNA has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Tuberous Sclerosis Complex-associated Refractory Seizures, Tuberous Sclerosis Complex.
Sponsors: Novartis Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Arizona · View every site in Phoenix
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
TGen/APNNA has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
TGen/APNNA has 2 clinical trials on record, with 1 currently active. Their work covers Tuberous Sclerosis Complex-associated Refractory Seizures, Tuberous Sclerosis Complex.
TGen/APNNA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.